FDA NDC Directory · JSON-LD · Markdown

fosaprepitant

NDC 71839-104 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerBE Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA212309
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsFOSAPREPITANT DIMEGLUMINE (150 mg/5mL)
Marketing started20191015
Package count1

External sources

Source: openFDA. Public-domain (CC0).